Does Lyrica Show Up on a 10 Panel Drug Test?

Quick answer: No. Lyrica (pregabalin) does not show up on a standard 10-panel urine drug test, because pregabalin is not one of the ten drug classes the panel screens for. Isolated false positives are possible on some immunoassays, and a lab can detect pregabalin only if it specifically orders that assay.

• A standard 10-panel cup or dip card has no pregabalin test line, so a legitimate Lyrica prescription will not normally cause a positive.
• Rare cross-reactivity reports mean any unexpected non-negative should go to lab confirmation, not be treated as final.
• If your policy needs pregabalin detection, you must order a specialty or LC-MS/MS lab test.

What a 10-panel drug test actually detects

A 10-panel urine test is an immunoassay screen. Each test line reacts to one drug or drug class above a set cutoff concentration. Panel makeup varies by manufacturer and by program, but a common configuration includes:

• Amphetamines (commonly 500 ng/mL for HHS-style screens; some panels use 1,000)
• Cocaine metabolite (150 ng/mL, or 300 on some panels)
• Marijuana metabolite, THC (50 ng/mL)
• Opiates (2,000 ng/mL HHS initial cutoff; some panels use 300)
• Phencyclidine, PCP (25 ng/mL)
• Barbiturates (commonly 300 ng/mL)
• Benzodiazepines (commonly 300 ng/mL)
• Methadone (commonly 300 ng/mL)
• Methaqualone (commonly 300 ng/mL)
• Propoxyphene, or on newer panels oxycodone, MDMA or buprenorphine in its place

Pregabalin is not on this list. The federal reference cutoffs for the five HHS drug classes are published in the SAMHSA Mandatory Guidelines for urine testing. The other five panel positions are set by the test manufacturer and are not federally regulated for workplace programs.

Why Lyrica is not on the panel

Lyrica is the brand name for pregabalin, a prescription medication used for nerve pain, seizures and fibromyalgia. The DEA classifies it as a Schedule V controlled substance. It is chemically unrelated to opioids, benzodiazepines or barbiturates, so the antibodies in a standard test do not target it. Federal workplace programs under HHS and DOT also do not include it in their required panels.

Can Lyrica cause a false positive?

Published case reports describe rare false-positive screens on certain immunoassays in patients taking pregabalin, and results vary by manufacturer and lot. This is not a common or expected result, but it is the reason a presumptive positive should never be the final word. A confirmatory test by GC-MS or LC-MS/MS separates a true positive from cross-reactivity because it identifies the specific molecule.

Screening options compared

Result-reading steps for your staff

Read the cup or card correctly

On most cups and dip cards, a line in the test region means negative for that drug, even a faint line. No line in a drug region means a non-negative (presumptive positive) for that drug. The control line must appear, or the test is invalid and should be repeated with a new device. Read within the time window in the manufacturer's instructions and do not read after it expires.

Handle a non-negative

A presumptive positive is a screening result only. Document the specimen, preserve it under chain of custody, and send it to a laboratory for confirmation. If the donor reports a Lyrica prescription and the flagged class is unrelated to it, note this for the reviewing physician rather than making the decision at the collection site.

Buyer checklist: choosing a panel

• Confirm which drug classes your policy actually requires, and whether pregabalin is among them.
• Check the cutoff (ng/mL) printed for each line in the package insert.
• Verify the device's FDA clearance status. Many urine drug screening devices are FDA 510(k) cleared, and professional-use products are generally sold for CLIA-waived settings. Ask your supplier for documentation rather than assuming.
• Confirm the panel configuration (propoxyphene versus oxycodone, for example).
• Set a written policy for presumptive positives and prescription disclosure.
• Arrange laboratory confirmation and medical review before you begin testing.
• Train collectors on temperature strips, adulterant checks and timing.

Where to source testing supplies

Clinics, courts, staffing firms and employers can buy multi-panel drug test cups at wholesale from American Screening Corp, along with dip cards, oral fluid tests and DOT-compliant collection kits. If your program needs a custom panel or lab confirmation workflow, contact our team and we will help match the device to your policy.

Frequently asked questions

Does Lyrica show up on a 10-panel drug test?

Not normally. Pregabalin is not one of the drug classes on a standard 10-panel screen, so a prescribed dose should not produce a positive result.

Can pregabalin cause a false positive on a urine drug screen?

Rare cross-reactivity has been reported on certain immunoassays. Any unexpected non-negative should go to GC-MS or LC-MS/MS confirmation before action is taken.

How can an employer or clinic test for pregabalin?

Order a laboratory test that specifically includes pregabalin, typically by LC-MS/MS. A standard point-of-collection cup will not provide this result.

Is Lyrica a controlled substance?

Yes. The DEA lists pregabalin as a Schedule V controlled substance, even though it is not part of standard federal workplace drug panels.

Sources

• SAMHSA: Workplace Drug Testing and Mandatory Guidelines
• DEA: Drug Scheduling
• MedlinePlus (NIH): Pregabalin

This article is general information, not legal or medical advice.